NCT05758480View on ClinicalTrials.gov

Characterization of the Immunometabolic Signature in Long COVID-19.

NAActive, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 24, 2023

Primary Completion Date

May 7, 2025

Study Completion Date

November 3, 2025

Conditions
Long COVID
Interventions
BIOLOGICAL

Blood sample (at inclusion and 6 months later)

(56ml of blood, 8 tubes) 3 heparin, 1 EDTA , 2 SST, 2 CPT

OTHER

Patient questionnaires (at inclusion and 6 months later)

(4 questionnaires) Symptoms in the last week, Fatigue Impact Scale (FIS), Short-Form 36 (SF-36) and Nijmegen.

Trial Locations (1)

49933

Angers University Hospital, Angers

All Listed Sponsors
lead

University Hospital, Angers

OTHER_GOV